Contact Congress about H.R. 3391: End Price Gouging for Medications Act

The bill would make the federal government set a maximum price for every prescription drug each year. Federal health plans could not pay more than that price, and drug makers would also have to offer it to private plans and uninsured people. Drug companies that overcharge federal programs could face steep fines.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

End Price Gouging for Medications Act is a House bill in committee. The latest recorded action: Referred to the Subcommittee on Health.

Latest action on H.R. 3391: Referred to the Subcommittee on Health.

Who this affects: This bill mainly affects people who get drugs through Medicare, Medicaid, TRICARE, veterans' health care, federal employee health plans, and Indian health programs, because those plans could not pay above the new federal price cap. It also affects people with private insurance and people without insurance, because drug companies would have to offer them prices that stay within the same limit. Drug manufacturers would face the biggest direct legal change, because they would have to follow the new pricing rules for the whole U.S. market or risk major fines.

Why this matters: This bill matters because it could lower what many health plans and patients pay for prescription drugs in the United States. It tries to do that by tying U.S. prices to lower prices in other wealthy countries and by extending that cap beyond federal programs. That could save money for government health plans, private coverage, and some uninsured people. But it could also change how drug companies price drugs, where they launch them, and how much money they expect to make in the U.S. market.

Key provisions in H.R. 3391

• The Health and Human Services Secretary would have to set a new price cap every year for each prescription drug sold in the United States.
• Big federal health programs could not pay more than that set price for covered drugs.
• When price data exist in at least three listed foreign countries, the U.S. cap must use the lowest of those foreign list prices.
• When there is not enough foreign data, the Secretary would set the price by looking at medical benefit, value, patient access, research and development costs, and other relevant factors.
• The rule would cover drugs paid for by Medicare, Medicaid, CHIP, TRICARE, veterans' health care, federal employee health plans, and Indian health programs and facilities.

How Modern Action helps you take action on H.R. 3391

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 3391

What is H.R. 3391?

The bill would make the federal government set a maximum price for every prescription drug each year. Federal health plans could not pay more than that price, and drug makers would also have to offer it to private plans and uninsured people. Drug companies that overcharge federal programs could face steep fines.

How do I support or oppose H.R. 3391?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about H.R. 3391?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

Can Modern Action explain H.R. 3391 before I act?

Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.